Tonix Pharmaceuticals Holding Corp.

TNXP Nasdaq SEC CIK 1430306
Follow Tonix Pharmaceuticals Holding Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $17.2M +423.8% vs same quarter last year
Net income −$53.3M −66.6% vs same quarter last year
EPS, diluted −$2.89 +19.5% vs same quarter last year
Operating cash flow −$41.1M −42.7% vs same quarter last year
Revenue by quarter
$2.6M
$2.4M
$2M
$3.3M
$5.4M
$6.9M
$13.5M
$17.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$13.1M−$124M
FY24$10.1M−$130M
FY23$7.8M−$116.7M
FY22-−$110.2M
FY21-−$92.3M
FY20-−$50.5M
FY19-−$28.6M
FY18-−$26.1M
FY17-−$21.1M
FY16-−$38.8M
FY15-−$48.1M
FY14-−$27.6M
FY13-−$10.9M
FY12-−$9.5M
FY11-−$3.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−2000%−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2549.3%−959.1%−946.2%
FY2423.1%−1354.3%−1288.3%
FY2339%−1523.9%−1501.8%
FY22---
FY21---
FY20---
FY19---
FY18---
FY17---
FY16---
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$103.2M
FY24−$61M
FY23−$109.9M
FY22−$146.2M
FY21−$110.9M
FY20−$57.1M
FY19−$26.7M
FY18−$24M
FY17−$19.1M
FY16−$37.4M
FY15−$42.6M
FY14−$23.2M
FY13−$8.5M
FY12−$5.7M
FY11−$2.6M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Tonix Pharmaceuticals Holding Corp.
  • Healthcare median
−2000%−1500%−1000%−500%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearTonix Pharmaceuticals Holding Corp.Healthcare median
FY25−946.2%−30.6%
FY24−1288.3%−47%
FY23−1501.8%−58%
FY22-−80.4%
FY21-−71.9%
FY20-−62.2%
FY19-−46.3%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15-−38.4%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%